Swedish Orphan, Under Pressure At Home, Looks to Commerical Swap With China Company For Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
The Nordic specialist, facing commercial difficulties at home and the loss of co-promotion deals for a handful of drugs, lines up the first product to be included in a pan-European product rights deal with Chinese partner Dongbao.